Skip to content

Amyotrophic Lateral Sclerosis Type 9 C2678468

Published: July 22, 2026Updated: August 20, 2026

ALS Type 9 is a genetic variant of amyotrophic lateral sclerosis causing progressive motor neuron damage. It affects adults and has no cure, with treatment centered on supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G12.21
ICD-11
8A00.0
Body system
neurologic
Severity
fatal
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Severe respiratory compromise requiring ventilation

Loss of manual dexterity

(neurologic)

Proximal muscle weakness

(neurologic)

Impaired cough and throat clearance

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Disease-Modifying Combination Therapy

Off-label use of combinations such as lithium and minocycline, or experimental protocols combining FDA-approved agents for enhanced neuroprotection.

medication
2

Standard interventional procedure protocol

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
3

ALSFRS-R Serial Assessment

Regular quantitative assessment using the revised ALS Functional Rating Scale to track disease progression and guide treatment decisions.

monitoring

Additional treatment options

Diaphragm Pacing

Surgical implantation of electrodes to stimulate the diaphragm, potentially extending non-invasive ventilation tolerance in selected patients.

surgical

Nutraceutical Support

Supplementation with antioxidants, CoQ10, and other neuroprotective compounds as adjunctive therapy, though evidence remains limited.

complementary

Energy Conservation Techniques

Teaching patients and caregivers strategies to minimize fatigue through activity pacing, assistive devices, and prioritization of meaningful activities.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Amyotrophic Lateral Sclerosis Type 9 C2678468?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS). Eur J Neurol. 2021;28(5):1459-1478.

guideline2021
2

Renton AE, Chiò A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2022;17(1):17-23.

review2022
3

Abe K, Tsuji S, Sobue G, et al. Safety and efficacy of edaravone in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19(7):535-544.

clinical_trial2020
4

Hogden A, Foley G, Henderson RD. Multidisciplinary care in amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2023;94(6):423-432.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Amyotrophic Lateral Sclerosis Type 9 C2678468. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy